Health
Sequencing Study from Roswell Park Highlights Previously Unknown Myeloma Resistance Mechanisms – Newswise
— A group of researchers led by Maximillian Merz, MD, Assistant Professor of Oncology with the Myeloma team at Roswell Park Comprehensive Cancer Center, condu
- First single-cell analysis in a prospective trial for patients with myeloma
- Plasma-cell clones responsible for characteristic bone lesions, team shows
- Findings suggest new strategies for eradicating minimal residual disease
Newswise — BUFFALO, N.Y. — A group of researchers led by Maximillian Merz, MD, Assistant Professor of Oncology with the Myeloma team at Roswell Park Comprehensive Cancer Center, conducted the first prospective clinical trial investigating spatial heterogeneity in patients with either…
Continue Reading
-
General21 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General23 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
General14 hours agoAustralia’s Diamonds defeat South Africa’s Proteas 65-42 in third netball Test
-
Noosa News18 hours agoSerious traffic crash, Noosa – Sunshine Coast